Lili Yang — SPARQNOW

At-a-Glance

Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles (UCLA)
Runs the Yang Engineering Immunity Lab, focused on tumor immunology and next-generation cancer immunotherapy
Scientific Founder of two biotech startups: Appia Bio (CAR-iNKT cell therapy) and Immune Design Corp (cancer vaccine, acquired by Merck)
Recipient of the TR35 Award, Director's New Innovator Award, and Outstanding New Investigator Award
Earned a Ph.D. in Biology from the California Institute of Technology

Biography

Lili Yang, Ph.D., is a Professor of Microbiology, Immunology, and Molecular Genetics at the University of California, Los Angeles (UCLA). At UCLA, she leads the Yang Engineering Immunity Lab, which conducts research on tumor immunology and aims to develop next-generation cancer immunotherapy.

Beyond her academic commitments, Dr. Yang is a Scientific Founder of two biotech startups.